Biodesix appoints Lawrence T. Kennedy to Board of Directors, effective Jan 3, 2023

BIODESIX INC

Kennedy appointed to Board and Audit Committee, effective Jan 3, 2023.
He brings 20+ years healthcare operating, finance, and investment experience; managing partner/CEO of Westwood Management.
Initial equity grant of $375K (50% NQSOs, 50% RSUs) plus prorated annual grant of $46,411 in RSUs.
Senior Mgmt Bonus to Equity Plan amended: Multiplier reduced from 4 to 3, and Company may limit election by percentage.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lawrence (Lair) T. Kennedy

Director

BDSX · BIODESIX INC

Effective: 2023-01-03
Filed: December 16, 2022, 6:59 PM ET

On December 15, 2022, Lawrence (Lair) T. Kennedy was elected and appointed to the Board of Directors of Biodesix, Inc. (the “Company”), with such appointment to be effective and service to commence on January 3, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lawrence (Lair) T. Kennedy was appointed as Director at BIODESIX INC.

Action: appointed
Role: Director

Exact text from the filing

On December 15, 2022, Lawrence (Lair) T. Kennedy was elected and appointed to the Board of Directors of Biodesix, Inc. (the “Company”), with such appointment to be effective and service to commence on January 3, 2023.

View on SEC.gov

BIODESIX INC filing history →

Source: SEC EDGAR

accession 0000950170-22-026669

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.